Home | mutebutton ®

Advancing the next generation of tinnitus treatment.

Building on positive clinical outcomes and patient experiences, in September 2015 we secured significant investment from the international life sciences venture capital fund Fountain Healthcare Partners. This investment will be used to further enhance the scientific and clinical understanding of bi-modal neuromodulation for treating chronic tinnitus, commence US clinical trials and to promote the adoption of mutebutton as a next generation treatment for chronic tinnitus. The ultimate goal is the international launch of the product in 2018.


Tinnitus is the perception of sound in the absence of a corresponding external stimulus. Often described as ‘ringing in the ears’, many people will have experienced tinnitus at some stage in their lives. 1 in 10 people live with tinnitus, with 1% of the population reporting significant issues such as anxiety, sleep deprivation and depression as a result of the condition.

Tinnitus is not a disease or a syndrome but rather a complex condition with many causes, symptoms and secondary complications. Tinnitus presents in many forms and a multi-disciplinary approach is generally recommended for its diagnosis and treatment.

If you are experiencing tinnitus symptoms it is wise to consult your doctor. For additional information on tinnitus contact your national tinnitus association.

About Mutebutton

Mutebutton is a technology that combines auditory and neural stimulation to promote positive therapeutic change in the parts of the brain that are implicated in tinnitus.

This technology is based on neuromodulation, a branch of medicine that stimulates parts of the nervous system in very specific ways, in order to promote normalisation of activity in the body's neural pathways.

The device simultaneously delivers mild stimulation to the tongue via the tonguetip™ and auditory stimulation through the headphones.

Clinical Evidence

  • Impact of acoustic and tactile multi-modal neuromodulation on objective and subjective measures of tinnitus C. Hamilton, B. Pearlmutter , B. Conlon and G. Crispino. Abstracts of the Fourth Joint Annual Conference, Experimental and Clinical Short Papers Meetings of the British Society of Audiology, International Journal of Audiology 2014; 53: 641–696.
  • Impact of acoustic and tactile multi-modal neuromodulation on objective and subjective measures of permanent intractable tinnitus R. O’Neill, C. Hamilton, B. Pearlmutter, G. Crispino, S. Hughes, B. Conlon. Proceedings of the Fifty Fourth Annual Meeting of the Irish Otolaryngology Society / Head and Neck Society, October 10-11th 2013.

To register your details for future Clinical Trials
Please sign up below

Contact Us

Full Name

Email Address



Click to confirm you have read our Privacy Policy